Bruker Corp. (BRKR) Scheduled to Post Quarterly Earnings on Friday
Bruker Corp. (NASDAQ:BRKR) is scheduled to be issuing its Q313 quarterly earnings data on Friday, November 1st. Analysts expect the company to announce earnings of $0.22 per share and revenue of $452.40 million for the quarter. Investors interested in listening to the company’s conference call can do so using this link.
Shares of Bruker Corp. (NASDAQ:BRKR) opened at 20.705 on Thursday. Bruker Corp. has a 52-week low of $12.10 and a 52-week high of $20.39. The stock’s 50-day moving average is $20.44 and its 200-day moving average is $18.50. The company has a market cap of $3.454 billion and a P/E ratio of 42.78.
A number of analysts have recently weighed in on BRKR shares. Analysts at Goldman Sachs Group Inc. raised their price target on shares of Bruker Corp. from $21.00 to $22.00 in a research note to investors on Friday, September 27th. They now have a “buy” rating on the stock. On a related note, analysts at Maxim Group initiated coverage on shares of Bruker Corp. in a research note to investors on Thursday, September 26th. They set a “buy” rating and a $27.00 price target on the stock. Finally, analysts at Cleveland Research initiated coverage on shares of Bruker Corp. in a research note to investors on Friday, September 20th. They set a “buy” rating on the stock. Five investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $22.68.
Bruker Corporation (NASDAQ:BRKR) is a global manufacturer of scientific instruments that address the rapidly evolving needs of a diverse array of customers in life science, pharmaceutical, biotechnology, clinical and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.